Supporting HIV/AIDS Epidemic Control in Botswana

As part of its strategy, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) approach for achieving epidemic control includes community-based antiretroviral therapy (ART) services—the provision of medicine to stable HIV patients outside of a health facility. In many countries, this approach has shown positive...

Botswana was one of the first countries in Africa to make HIV treatment available within its public health sector. According to UNAIDS, in 2017 84 percent of people living with HIV were accessing treatment. However, Botswana is still one of the countries most affected by...

Dr. Dintle Molosiwa joins HRH2030 as the new project director for our Botswana activity. Prior to joining Chemonics, Dintle worked as a health management and financing consultant at University Research Co. Additionally, Dintle has worked at the Botswana Ministry of Health in the Department of Clinical...

Botswana, as one of the countries most affected by the HIV/AIDS epidemic, was among the first to embrace community-centered primary health in the late 1970s. However, despite noteworthy progress in reducing HIV-related mortality and morbidity owing to the spirited antiretroviral therapy (ART) program launched in...

Kesaobaka Dikgole is a senior quality improvement advisor with HRH2030 in Botswana while also serving as a country representative for the University Research Co. (URC). She oversees the technical team to design, test, and evaluate care innovations to improve patient-centered HIV care as part of...

After a decades-long effort, The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) recently recognized Botswana as one of 13 high-burden countries that have the potential to achieve HIV/AIDS epidemic control by 2020. To support the country’s efforts and sustain its successes, the HRH2030 program,...